G3-R is a high-purity synthetic peptide analog engineered to interact with three key metabolic receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the Glucagon receptor. This triple-agonist receptor profile has positioned G3-R as a compelling compound of interest across a broad range of preclinical metabolic research applications.
Research Interest Areas
G3-R is currently investigated in laboratory settings for its role in metabolic pathway signaling, energy homeostasis modeling, and incretin-based receptor activity. Its unique receptor binding profile makes it a subject of interest in studies exploring appetite regulation mechanisms, lipid and glucose metabolism pathways, and energy expenditure dynamics at the cellular level.
Technical Specifications
| Parameter | Detail |
|---|---|
| Purity | ≥99% (HPLC verified) |
| Form | Lyophilized powder |
| Vial Sizes | 10mg / 20mg |
| Reconstitution | Bacteriostatic water |
| Storage | 2–8°C upon receipt |
| Handling | Protect from heat, moisture, and direct light |
Classification
G3-R is classified as a synthetic incretin-glucagon receptor analog. Its structural basis draws from established incretin and glucagon-receptor signaling research, offering investigators a tool compound for exploring multi-receptor agonism within controlled research environments.
This product is intended for in vitro and laboratory research purposes only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease or condition.
